Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
about
Reconstructing skin cancers using animal modelsContribution of chaperones to STAT pathway signaling.Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migrationImiquimod induces apoptosis of squamous cell carcinoma (SCC) cells via regulation of A20.From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.Synergy of understanding dermatologic disease and epidermal biology.Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenograftsTargeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis.Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.Pharmacologic treatment options for advanced epithelial skin cancer.Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion.Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.FYNagling divergent adhesive functions for Fyn in keratinocytes.
P2860
Q27024320-74B8462C-4760-42CC-81B0-BF410D0CF736Q27687561-9BD96A8F-D2A0-4163-838E-206E13D1C09EQ28235184-999F2148-8647-4F24-B830-FF79E32F5B5AQ35151677-64E7F517-45BD-4D42-9E1F-2F3C10E18FA6Q35698913-DCD3F6BB-B8FC-4262-B140-7A1482F8BEE6Q35699059-F46E114B-21C4-4B0A-82C0-88CDA981D6E2Q36455713-7D23C795-9FF9-49D1-8266-7182DD08ABB5Q36927030-676D1716-8564-45B7-8194-ED9C1BD6E5E3Q37026588-7CA655D6-16FE-4C1D-8D13-55F5FAAD452DQ38187197-8078E0B2-8CE1-484A-BAAB-1F01ACB60E4AQ38509273-20B6146D-47BE-4F43-A7AF-E0B950B0F468Q38684394-57AEECF0-66F2-4A17-A7B9-30F08FDB60FBQ38755893-26F6D0CD-A58B-44BB-8C61-95979AAA9DEEQ38979793-228ABF94-8354-45D3-8141-E9A27EB121EDQ39308756-16F9D32F-61BC-4EA1-ABE7-0EE89D35DA27Q41868155-82948EC5-5A7B-4B09-86E8-6A09EC11E98BQ54341168-66BAA774-DC00-4DA7-9327-3DF979F023A6
P2860
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@en
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@nl
type
label
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@en
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@nl
prefLabel
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@en
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
@nl
P2093
P2860
P1433
P1476
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53
@en
P2093
Adrienne Werth
Christine Marshall
Christopher Miller
Hasan Bashir
John T Seykora
Liang Zhao
Matthew Hanson
Thomas Griffin
Tzvete Dentchev
P2860
P304
P356
10.1158/0008-5472.CAN-09-2976
P407
P577
2009-12-01T00:00:00Z